These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. Busam KJ, Wanna M, Wiesner T. JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620 [Abstract] [Full Text] [Related]
26. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. PLoS One; 2012 Mar; 7(4):e35295. PubMed ID: 22545102 [Abstract] [Full Text] [Related]
27. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P. JAMA Dermatol; 2017 Oct 01; 153(10):999-1006. PubMed ID: 28793149 [Abstract] [Full Text] [Related]
28. Gene of the month: BAP1. Wang A, Papneja A, Hyrcza M, Al-Habeeb A, Ghazarian D. J Clin Pathol; 2016 Sep 01; 69(9):750-3. PubMed ID: 27235536 [Abstract] [Full Text] [Related]
29. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. McDonnell KJ, Gallanis GT, Heller KA, Melas M, Idos GE, Culver JO, Martin SE, Peng DH, Gruber SB. Cancer Genet; 2016 Mar 01; 209(3):75-81. PubMed ID: 26774355 [Abstract] [Full Text] [Related]
30. Beyond typical histology of BAP1-inactivated melanocytoma. Donati M, Kazakov DV. Pathol Res Pract; 2024 Jul 01; 259():155162. PubMed ID: 38326181 [Abstract] [Full Text] [Related]
31. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus. Ardakani NM, Palmer DL, Wood BA. Pathology; 2015 Dec 01; 47(7):707-10. PubMed ID: 26517632 [No Abstract] [Full Text] [Related]
32. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome. Moawad S, Reigneau M, de la Fouchardière A, Soufir N, Schmutz JL, Granel-Brocard F, Phan A, Bursztejn AC. Br J Dermatol; 2018 Oct 01; 179(4):973-975. PubMed ID: 29754391 [No Abstract] [Full Text] [Related]
33. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Am J Dermatopathol; 2019 Mar 01; 41(3):167-179. PubMed ID: 30801340 [Abstract] [Full Text] [Related]
37. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma. Ewens KG, Lalonde E, Richards-Yutz J, Shields CL, Ganguly A. BMC Cancer; 2018 Nov 26; 18(1):1172. PubMed ID: 30477459 [Abstract] [Full Text] [Related]
38. The elusive BAP1 mutation in pediatric melanocytic tumors. Moustafa D, Mologousis MA, Duncan LM, Hawryluk EB. Pediatr Dermatol; 2024 Nov 26; 41(5):822-824. PubMed ID: 39076037 [Abstract] [Full Text] [Related]
39. A population-based analysis of germline BAP1 mutations in melanoma. O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ. Hum Mol Genet; 2017 Feb 15; 26(4):717-728. PubMed ID: 28062663 [Abstract] [Full Text] [Related]
40. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers. Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E. Klin Onkol; 2019 Feb 15; 32(Supplementum2):118-122. PubMed ID: 31409087 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]